Canada’s Blind Spot on Drug Safety in Pregnancy – SOGC
The Society of Obstetricians and Gynaecologists of Canada (SOGC) shared a post on LinkedIn:
“A new op-ed published in the Montreal Gazette, co-authored by SOGC CEO Dr. Diane Francoeur and SOGC member Prof. Anick Bérard, highlights a critical gap in women’s health: the lack of robust data on the safety of medications during pregnancy.
Dr. Francoeur and Prof. Bérard note that most prescription drugs approved in Canada lack adequate safety data for use in pregnancy, leaving patients and physicians to make important decisions without clear evidence.
They call for stronger national data infrastructure, sustained investment in women’s health research and better integration of real-world evidence to change behaviour and improve outcomes.
Read the full op-ed.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 15, 2026, 18:18A PCOS Diagnosis Can Stay in the Background of Every Fertility Conversation – Banker IVF and Women’s Hospital
-
Sep 15, 2026, 18:15The Difference Between Ovulation Induction and Ovarian Stimulation – Fertility Plus
-
Sep 15, 2026, 18:13Ritu Anand: What Would I Tell an IVF Couple in the 1980s?
-
Sep 15, 2026, 18:11STP Curriculum Feedback Survey – The Association of Reproductive and Clinical Scientists
-
Sep 15, 2026, 18:09Khushi Mishra: ICSI – Where Precision Meets the Possibility of Life
-
Sep 15, 2026, 18:06Khalil Faaed: The Future of niPGT-A Is Not Just Non-Invasive…
-
Sep 15, 2026, 18:04Anuradha Housnur: ICSI Is Not About Injecting the Sperm…
-
Sep 15, 2026, 18:02Snehal Kaware: Can an Oocyte With a Vacuole Still Fertilize?
-
Sep 15, 2026, 17:59Kanishka Gaur: Amenorrhea Is a Symptom, Not a Diagnosis
